Inverted terminal repeat sequences of adeno-associated virus enhance the antibody and CD8(+) responses to a HIV-1 p55Gag/LAMP DNA vaccine chimera (Q40546383)

From Wikidata

Jump to navigation Jump to search

scientific article published on June 2004

Language	Label	Description	Also known as
English	Inverted terminal repeat sequences of adeno-associated virus enhance the antibody and CD8(+) responses to a HIV-1 p55Gag/LAMP DNA vaccine chimera	scientific article published on June 2004

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Inverted terminal repeat sequences of adeno-associated virus enhance the antibody and CD8(+) responses to a HIV-1 p55Gag/LAMP DNA vaccine chimera (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Ernesto T A Marques

7

object named as

Ernesto T A Marques

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

4

object named as

Barry Byrne

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

author name string

Priya Chikhlikar

1

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Luciana Barros de Arruda

2

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Shikha Agrawal

3

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

William Guggino

5

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

J Thomas August

6

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

language of work or name

0 references

publication date

1 June 2004

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

number of pages

13

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

323

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

220-232

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Linear DNAs concatemerize in vivo and result in sustained transgene expression in mouse liver

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.025

7 January 2021

Humoral immunity to adeno-associated virus type 2 vectors following administration to murine and nonhuman primate muscle

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.025

7 January 2021

Uniform GFP-expression in transgenic medaka (Oryzias latipes) at the F0 generation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.025

7 January 2021

Multiple effects of codon usage optimization on expression and immunogenicity of DNA candidate vaccines encoding the human immunodeficiency virus type 1 Gag protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.025

7 January 2021

Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.025

7 January 2021

Structural analysis of adeno-associated virus transduction circular intermediates.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.025

7 January 2021

Transient transgenesis in Xenopus laevis facilitated by AAV-ITRs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.025

7 January 2021

Enhanced expression and stable transmission of transgenes flanked by inverted terminal repeats from adeno-associated virus in zebrafish

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.025

7 January 2021

CD4(+) T cell effectors can become memory cells with high efficiency and without further division.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.025

7 January 2021

Human immunodeficiency virus type 1-specific immunity after genetic immunization is enhanced by modification of Gag and Pol expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.025

7 January 2021

Effector and memory T-cell differentiation: implications for vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.025

7 January 2021

Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.025

7 January 2021

Mapping and direct visualization of a region-specific viral DNA integration site on chromosome 19q13-qter

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.025

7 January 2021

A Rev-independent human immunodeficiency virus type 1 (HIV-1)-based vector that exploits a codon-optimized HIV-1 gag-pol gene

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.025

7 January 2021

HIV-1 p55Gag encoded in the lysosome-associated membrane protein-1 as a DNA plasmid vaccine chimera is highly expressed, traffics to the major histocompatibility class II compartment, and elicits enhanced immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.025

7 January 2021

Free DNA ends are essential for concatemerization of synthetic double-stranded adeno-associated virus vector genomes transfected into mouse hepatocytes in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.025

7 January 2021

AAV serotype 2 vectors preferentially integrate into active genes in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.025

7 January 2021

Helper-independent and AAV-ITR-independent chromosomal integration of double-stranded linear DNA vectors in mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.025

7 January 2021

Pathways of removal of free DNA vector ends in normal and DNA-PKcs-deficient SCID mouse hepatocytes transduced with rAAV vectors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.025

7 January 2021

Constructing polycompetitor cDNAs for quantitative PCR.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.025

7 January 2021

Effect of DNA-dependent protein kinase on the molecular fate of the rAAV2 genome in skeletal muscle

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.025

7 January 2021

Lineage relationship and protective immunity of memory CD8 T cell subsets

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.025

7 January 2021

A novel recombinant adeno-associated virus vaccine induces a long-term humoral immune response to human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.025

7 January 2021

A DNA vaccine containing inverted terminal repeats from adeno-associated virus increases immunity to HIV.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.025

7 January 2021

Double strand interaction is the predominant pathway for intermolecular recombination of adeno-associated viral genomes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.025

7 January 2021

Increased expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 gag gene

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.025

7 January 2021

Circular intermediates of recombinant adeno-associated virus have defined structural characteristics responsible for long-term episomal persistence in muscle tissue

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.025

7 January 2021

Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.025

7 January 2021

based on heuristic

inferred from DOI database lookup

Concatamerization of adeno-associated virus circular genomes occurs through intermolecular recombination.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.025

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VIROL.2004.02.025

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40546383&oldid=1900242390"